Invirsa

Columbus, OH · Founded 2014 · Privately Held (backing)

Developer of a therapeutic platform designed to treat infectious and inflammatory eye diseases through activation of innate cellular defense and repair pathways. Invirsa is based in Columbus, OH and was founded in 2014. Its last reported valuation was $38 million in Nov 2023. It has raised $14.3 million across 3 recorded rounds; the latest was a $2.9 million seed round in Jul 2025.

Last reported valuation
$38.0M
Oct 2026
Priced at
—
Total raised
$14.3M
Last round
Seed Round
Jul 2025
Cap table — not yet on record

Invirsa's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Invirsa with a free account
  • ·Watch Invirsa: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about Invirsa

Where does Invirsa's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Invirsa's 3 recorded funding rounds.